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ABSTRACT
Background: Slow spaced eating is associated with
improved satiety and gut hormone responses in normal-
weight participants. This crossover study compared the
effect of slow and rapid eating patterns on hunger,
fullness, glucose, insulin, and the appetite-related gut
hormones peptide YY (PYY), glucagon-like peptide-1
(GLP-1), and ghrelin in overweight and obese
participants with type 2 diabetes mellitus (T2DM).
Methods: 20 overweight and obese participants with
T2DM on metformin were recruited. A test meal of
300 mL ice-cream was consumed in random order in
two different sessions by each participant; meal
duration was 5 or 30 min. Fullness and hunger as
assessed by visual analog scales (VAS), and glucose,
insulin, PYY, GLP-1, and ghrelin were measured at
baseline and at 30 min intervals after meal termination
for 3 h.
Results: Fullness VAS ratings were significantly higher
at the 90’, 120’, 150’, and 180’ time points and hunger
ratings were lower at 90’, 150’, and 180’ for the 30 min
meal. The area under the curve (AUC) for fullness was
higher after the 30 min meal than after the 5 min meal
(11 943.7±541.2 vs 10 901.0±568.8 mm min, p=0.003)
whereas the hunger AUC was lower (4442.9±328 vs
4966.7±347.5 mm min, p=0.012). There were no
differences in glucose, insulin, PYY, GLP-1, and ghrelin
responses.
Conclusions: Slow spaced eating increased fullness
and decreased hunger ratings in overweight and obese
participants with T2DM, without the improvement in gut
hormone responses found in normal-weight
participants. Slow spaced eating may be a useful
prevention strategy, but might also help curb food
intake in those already suffering from obesity and
diabetes.
INTRODUCTION
Diabetes is considered a contemporary epi-
demic, and not without reason. More than
300 million people are estimated to suffer
from diabetes globally, with type 2 diabetes
mellitus (T2DM) making up about 90% of
the cases.1 Insulin resistance as a conse-
quence of obesity, along with impaired
insulin production, has traditionally been
considered the main pathophysiological
feature of T2DM.2 The incretin effect, an
important link between gut hormones, appe-
tite, and glycemia, has been shown to be
impaired in patients with type 2 diabetes.3
A number of gut hormones including
incretins have important physiological roles
in the regulation of hunger and satiety. The
immediate postprandial state is characterized
by a decrease in the concentrations of the
orexigenic gut hormone ghrelin, coupled
with an increase in anorexigenic peptides,
such as cholecystokinin, peptide YY (PYY),
and glucagon-like peptide-1 (GLP-1).4 These
changes act in concert on the brain to
induce an eventual decrease in hunger,
increase in satiety, and meal termination.
Incretin analogs have beneﬁcial effects on
glycemic control and body weight in T2DM.5
Eating quickly is associated with reduced
satiety, increased body weight and insulin
resistance,6–8 while eating slower has been
shown to favor weight loss.9 We recently
showed that eating slowly increases the
Key messages
▪ Slow spaced eating does not affect glucagon-like
peptide-1 and peptide YY responses in partici-
pants with type 2 diabetes mellitus (T2DM) as it
does in healthy participants.
▪ Slow spaced eating led to substantial increase in
ratings of fullness and decrease in ratings of
hunger.
▪ This simple behavioral modification could be a
useful tool for limiting caloric intake in an over-
weight/obese population with T2DM, in which
weight control is a key issue.
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postprandial response of the anorexigenic peptides PYY
and GLP-1 in healthy participants.10 The effect of eating
rate on hunger, satiety, and the gut peptides PYY, GLP-1,
and ghrelin in patients with T2DM has not been studied
so far to the best of our knowledge. Given the rates of
obesity in this patient population, the insulin resistance
which characterizes this condition, and the recent intro-
duction of incretin analogs as therapeutic options for
diabetes, the present study aimed at exploring whether
slow spaced eating would alter the postprandial percep-
tion of hunger and satiety, as well as three gut peptides
related to appetite regulation in patients with type 2
diabetes.
PARTICIPANTS AND METHODS
All procedures were compliant with the Declaration of
Helsinki and the experimental protocol was approved by
the local hospital ethics committee. Twenty overweight
and obese patients were recruited from our university
hospital diabetes outpatient clinic. All patients gave
written informed consent. Inclusion criteria were the
presence of metformin-treated T2DM with good gly-
cemic control (glycated hemoglobin <7%) and body
mass index (BMI) ≥25 kg/m2. Patients requiring any
other medication that could interfere with hunger or
fullness or their postprandial glycemic and hormonal
responses were excluded.
The study visits were performed in random order and
at least 1 week apart from each other. On the day of
each visit, all participants arrived at the clinical research
facility after a 10 h overnight fast, without having taken
their morning doses of metformin. Their weight, height,
waist and hip circumference were measured and their
BMI and waist-to-hip ratio calculated.
The patients consumed the same standard test meal
of 300 mL of ice-cream (675 kcal, 59% of kcal fat, 33%
carbohydrates, 8% protein) at different rates. In one
session, the meal was weighed and divided into two
equal portions of 150 mL, which were consumed 5 min
apart, whereas in the other it was divided into seven
equal portions of ∼43 mL, given to the participant every
5 min and consumed over 30 min. Participants were spe-
ciﬁcally instructed to consume each portion in less than
1 min, in order to maintain a uniform rate of meal
ingestion. Blood samples for the measurement of
glucose, insulin, triglycerides, ghrelin, PYY, and GLP-1
were collected before the meal and at 30 min intervals
after the beginning of meal consumption until the end
of the session 180 min later. At the same time points,
patients were asked to answer the questions “how
hungry do you feel?” and “how full do you feel?” using
10 cm horizontal visual analog scales (VAS) with the
anchors ‘not at all’ and ‘extremely’.
Analytical methods
Serum glucose was measured with the oxidase–peroxid-
ase method (Zaﬁropoulos, Athens, Greece). Triglycerides
were measured enzymatically on an RA-XT analyzer
(Technicon, Dublin, Ireland). Serum insulin was assayed
with a commercially available RIA kit (Biosure, Brussels,
Belgium; coefﬁcient of variation (CV) 3.3±1.2%). GLP-1
and PYY were measured using established in-house
RIAs,10 while plasma total ghrelin was measured using a
commercially available ELISA kit (Millipore, Billerica,
Massachusetts, USA). The GLP-1 assay detected changes
of 7.5 pmol/L, with an intra-assay CV of 6.1%. The PYY
assay measured total PYY-like immunoreactivity and
detected changes of 2 pmol/L, with an intra-assay CV of
5.8%. The ghrelin assay measured octanoyl and des-
octanoyl ghrelin with an intra-assay CV of 5.1%.
Statistical analysis
Results are reported as mean±SEM. All parameters,
including hormonal responses and appetite ratings,
were compared between the two sessions for each indi-
vidual time point using two-tailed, paired Student t tests
(SPSS V.21, Chicago, Illinois, USA). The overall post-
prandial responses were assessed for each parameter as
area under the curve (AUC) using the trapezoid rule.
Postprandial AUC for appetite sensations has been
shown to be a strong predictor of ad libitum energy
intake.11 Values were compared using two-tailed, paired
Student t tests (SPSS V.21, Chicago, Illinois, USA).
RESULTS
Baseline characteristics of the study participants are dis-
played in table 1 and postprandial responses in table 2.
The 20 patients who were recruited had T2DM for
approximately 5 years. Sixty-ﬁve percent were overweight
and 35% obese. There were no signiﬁcant differences
between the two study visits for each speciﬁc time point
or for the overall postprandial response in glucose,
insulin, triglycerides, ghrelin, PYY, or GLP-1, as
expressed in terms of AUC (table 2).
Fullness VAS ratings were higher for the 30 min meal
at the 90 min time point and remained so until the end
of the study session (ﬁgure 1A). Differences between
the 30 and 5 min meal for each time point were 0.3±2.3
Table 1 Baseline characteristics of the study participants
(mean±SEM)
Overweight/obese participants (n) 13/7
Age (years) 62.6 ±1.8
Weight (kg) 87.0±4.4
Height (cm) 167.9±2.1
BMI (kg/m2) 30.6±1.1
Waist circumference (cm) 106.2±3.6
Hip circumference (cm) 104.4±3.7
Waist-to-hip ratio 1.02±0.01
Diabetes duration (years) 4.7±0.6
HbA1c (%) 6.75±0.06
Overweight/obese BMI (kg/m2) 27.5±0.3/36.2 ± 1.5
BMI, body mass index; HbA1c, glycated hemoglobin.
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(p=0.9) at 0 min, 0.4±2.9 (p=0.9) at 30 min, 3.6±2.6
(p=0.18) at 60 min, 7±1.9 (p=0.001) at 90 min, 6.8±2.5
(p=0.01) at 120 min, 8.8±2.6 (p=0.003) at 150 min, and
10.3±2.7 mm (p=0.001) at 180 min.
Hunger VAS ratings were lower for the 30 min meal at
the 90’, 150’, and 180’ time points (ﬁgure 1B).
Differences between the 30 and 5 min meal for each time
point were 2.5±3.1 (p=0.4) at 0 min, −4.1±2.1 (p=0.07) at
30 min, −2.7±2.6 (p=0.3) at 60 min, −5.3±2.1 (p=0.02) at
90 min, −4.2±2.7 (p=0.14) at 120 min, −6.2±2.5 (p=0.02)
at 150 min, and −6.5±2 mm (p=0.004) at 180 min.
Furthermore, fullness AUC was signiﬁcantly higher after
the 30 min meal than after the 5 min meal, whereas
hunger AUC was signiﬁcantly lower (table 2).
DISCUSSION
The aim of the present study was to assess the effect of
slow spaced eating on hunger and satiety ratings and
hormonal mediators in patients with T2DM treated with
metformin. The overall postprandial response for
insulin, glucose, triglycerides, the orexigenic hormone
ghrelin, and the anorexigenic peptides GLP-1 and PYY
was not signiﬁcantly different when patients ate a ﬁxed-
portion meal at a fast or slow spaced rate.
Ghrelin, a gastric peptide hormone, increases hunger
through its action on the arcuate hypothalamic nucleus.
Ghrelin concentrations rise in the fasting state and
decrease rapidly after food ingestion.12 Young healthy
Chinese men showed lower postprandial ghrelin concen-
trations and lower energy intake when food was chewed
40 instead of 10 times.13 In our study, a similar, but not
identical, manipulation of food ingestion did not have
the same results. However, in the present study, food was
ingested in a semiliquid state without being chewed, and
the participants were overweight and obese middle-aged
patients with T2DM. These differences could account
for the discrepant results.
PYY and GLP-1 are secreted by endocrine L cells in
the small bowel. Their plasma concentrations increase
postprandially, enhancing the feeling of satiety.4 We
showed that eating slower increased postprandial levels
of PYY and GLP-1 in healthy volunteers.10 This has been
supported by recent ﬁndings, especially in lean adults
and obese adolescents.9 13 14 We were not able to repli-
cate these ﬁndings in the present study of overweight
and obese patients with T2DM.
Our results did not come as a surprise, as it has been
well established that the incretin effect is blunted in
overweight and obese patients with T2DM.3 A recent
study also found that obese adults were not able to
increase postprandial PYY and GLP-1 responses when
they ate slower.14 Our patients were not only overweight
and obese but also had diabetes, and this could explain
the blunted gut peptide response we observed,
Table 2 Postprandial responses of the study participants (mean±SEM)
5 min Meal 30 min Meal Difference* df t p Value
Glucose AUC (mg/dL ×min) 28 687.7±1490.9 28 566.8±1557.9 120.9±496.4 19 0.24 0.81
Insulin AUC (IU/L ×min) 6793.7±940.1 6752.4±1015.2 41.3±321.1 19 0.13 0.90
Triglycerides AUC (mg/dL ×min) 24 203.8±2392.2 24 468.7±2085.1 −264.9±860.0 19 −0.31 0.76
Ghrelin AUC (pg/mL ×min) 39 275.9±4359.1 40 733.8±5191.7 −1457.9±1395.0 19 −1.05 0.31
PYY AUC (pmol/L ×min) 10 570.9±1550.2 9740.0±974.8 830.9±831.4 19 0.99 0.34
GLP-1 AUC (pmol/L ×min) 7414.0±948.9 7159.4±827.6 254.6±356.7 19 0.71 0.49
Fullness AUC (mm ×min) 10 901.0±568.8 11 943.7±541.2 −1042.7±301.9 19 −3.45 0.003
Hunger AUC (mm×min) 4966.7±347.5 4442.9±328.0 523.8±188.2 19 2.78 0.012
*Difference between the 5 and 30 min meal.
AUC, area under the curve; df, degrees of freedom; GLP-1, glucagon-like peptide-1; PYY, peptide YY.
Figure 1 Visual analog scale (VAS) ratings for fullness (A)
and hunger (B) after a 5 and 30 min meal (*p<0.01, §p<0.05).
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conﬁrming results from Rigamonti et al14 in patients
with obesity but no diabetes. The different PYY and
GLP-1 responses between obese adolescents and adults
in the latter study is intriguing; it could be interpreted
as a progressive impairment of the effect of slow eating
on gut peptides as obesity becomes a chronic condition.
On the other hand, Rigamonti et al found no differences
in VAS measures between the two eating conditions in
their obese adult group, whereas in the present study
there was a distinct effect of slow spaced eating, favoring
less hunger and more fullness. This discrepancy may be
due to the fact that in the study by Rigamonti et al, adult
participants were markedly more obese than in the
present study (mean BMI 44.1 vs 30.6 kg/m2) and did
not have T2DM. Nonetheless, it must be acknowledged
that the current study design did not allow us to distin-
guish between the effects of overweight/obesity and
T2DM on hunger and fullness perception or gut
peptide responses.
Postprandial levels of insulin, glucose, and triglycer-
ides were not affected by eating rate.10 14 Despite this, a
recent study in healthy individuals demonstrated that an
increased number of masticatory cycles reduced appetite
and increased postprandial responses of gut hormones,
glucose, and insulin.6 This was not evident by the AUC
for insulin, glucose, and triglycerides in the present
study, possibly owing to the diabetic state itself.
The most important ﬁnding of the present study is
that slow spaced eating, but still at a physiologically mod-
erate pace, resulted in a decrease in hunger and an
increase in fullness, as quantiﬁed through VAS ratings in
patients with T2DM. This could suggest that advising
patients with diabetes to pace themselves when eating
could be beneﬁcial as far as caloric intake is concerned.
Consistent with this is the association between eating
slower and lower BMI in patients with T2DM,15 while
two other studies have reported an association of thor-
ough mastication with improved glycemic response,
decreased postprandial appetite, and even prevention of
T2DM occurrence.16 17 It is not clear whether the effect
slow spaced eating has on perceived appetite translates
into reduced food consumption. A study in healthy lean
women showed lower ad libitum energy intake and
increased satiety when a meal was completed in 29 vs
8.6 min.18 In a recent study, eating slowly decreased ad
libitum food intake in normal weight but not overweight
and obese participants, but led to lower hunger ratings
in both.19 Whether our ﬁndings would translate into less
ad libitum food consumption cannot be gleaned from
that study, since it assessed hunger for only 60 min and
did not include diabetic individuals. Eating quickly has
also been associated with obesity and cardiovascular risk
factors in healthy and diabetic individuals.20
Appetite is regulated by a close interplay between the
digestive tract, adipose tissue, and the brain, in which
peripheral signals and numerous neuronal circuits,
among them serotoninergic, dopaminergic, endocanna-
binoid and opioid-related, as well as cognitive and
hedonic perceptions, interact.21 The effect of slow
eating on perceived hunger is thus more complex than
what can be distilled from only measuring three gut
hormone responses. The emerging pattern would
suggest that the normal physiological responses of gut
hormones and appetite control as observed in normal-
weight participants can be disturbed by weight gain and
is possibly further deranged by T2DM. Thus advising
patients to pace themselves when eating could be poten-
tially more helpful in the prevention of obesity in partici-
pants with intact physiological responses, rather than for
patients with established pathological responses, such as
those with obesity and T2DM. Still, eating slower may be
a good way of reducing caloric intake during a meal in
obese or overweight patients with T2DM, and potentially
translate to weight loss and glycemic improvements.
Although we found no differences in the postprandial
responses for the three hormones we measured, the
intervention was not necessarily ineffective, since partici-
pants felt fuller and less hungry. Slow spaced eating may
have affected other hormonal or neuronal mechanisms
that we did not measure, and this could be an interest-
ing area for future study.
To the best of our knowledge, this is the ﬁrst study
aimed to assess the effect of eating rate on hunger and
fullness as well as appetite-related gut hormones in
patients with T2DM. We chose patients on metformin
only in order to eliminate the possible confounding
effect of drugs interfering with insulin secretion or
incretin metabolism.
A limitation of our study is the fact that meal con-
sumption was not continuous, but instead consisted of
discreet, differently sized portions consumed at different
intervals. Thus, the possibility remains that the differ-
ences in fullness and hunger could in fact be the result
of a spacing and portion size effect. Still, the method
used was designed to maintain a uniform rate of con-
sumption, and has been used for this purpose previously
by our group and others.10 14 On the other hand, a self-
selected rate would be subject to increased variability
and make results more difﬁcult to interpret.
Furthermore, the 30 min meal duration almost exactly
corresponds to what has been previously described in ad
libitum meal studies,18 19 and is also physiologically
relevant.
The fact that we only recruited overweight and obese
participants could be regarded as another limitation of
the study. However, this was a conscious decision, since
this group is quite representative of patients in diabetes
clinics worldwide.
In conclusion, slow spaced eating increased satiety and
suppressed hunger more effectively than rapid eating in
overweight and obese patients with T2DM. This was not
accompanied by statistically signiﬁcant differences in
GLP-1, PYY, or ghrelin responses. Prevention is certainly
better than cure and maybe more emphasis should be
placed on eating at a slower pace in normal-weight non-
diabetic participants as they potentially stand to gain
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most. Still, eating slower could possibly help overweight
and obese patients with diabetes attenuate their appe-
tite, thus promoting weight loss and glycemic control.
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